Eprosartan-d3

• Catalog No.: E590102
• M. F.: C23H24N2O4S
• M. W.: 424.51266
• Storage: -20°C Freezer

SYNONYMS

• IUPAC name: 4-({2-[(4,4,4-^2H₃)butyl]-5-[(1E)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
• IUPAC Traditional name: 4-({2-[(4,4,4-^2H₃)butyl]-5-[(1E)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]imidazol-1-yl}methyl)benzoic acid
• Synonyms: SKF 108566-d3; Teveten-d3; (αE)-α-[[2-(Butyl-d3)-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid; SKB 108566-d3; (E)-2-(Butyl-d3)-1-(p-carboxybenzyl)-α-2-thenylimidazole-5-acrylic Acid; Navixen-d3

PROPERTIES

• Apperance: Off-White Solid
• Melting Point: >235°C (dec.)
• Solubility: Chloroform: Methanol; 1: 1
• Solubility: DMSO
• Storage Condition: -20°C Freezer

DETAILS

Description (English)

Labelled Eprosartan, a prototype of the imidazoleacrylic acid angiotensin II receptor antagonists. Eprosartan is an antihypertensive.

REFERENCES

• Edwards, R.M., et al.: J. Pharmacol. Exp. Ther., 260, 175 (1992)
• Schambye, H.T., et al.: Mol. Pharmacol., 47, 425 (1992)
• Tenero, D., et al.: Biopharma Drug Dispos., 19, 351 (1992)
• Elliott, W.J., et al.: J. Hum. Hypertens., 13, 413 (1999)